178 related articles for article (PubMed ID: 31220774)
1. Sp1-induced LncRNA CTBP1-AS2 is a novel regulator in cardiomyocyte hypertrophy by interacting with FUS to stabilize TLR4.
Luo X; He S; Hu Y; Liu J; Chen X
Cardiovasc Pathol; 2019; 42():21-29. PubMed ID: 31220774
[TBL] [Abstract][Full Text] [Related]
2. Circ-TLR4 promotes cardiac hypertrophy through recruiting FUS to stabilize TLR4 mRNA.
Li C; Wang J; Feng J; Zhou J; Hou L; Gao Y; Cheng Z
J Interv Card Electrophysiol; 2022 Oct; 65(1):153-163. PubMed ID: 35553305
[TBL] [Abstract][Full Text] [Related]
3. The H19 long noncoding RNA is a novel negative regulator of cardiomyocyte hypertrophy.
Liu L; An X; Li Z; Song Y; Li L; Zuo S; Liu N; Yang G; Wang H; Cheng X; Zhang Y; Yang X; Wang J
Cardiovasc Res; 2016 Jul; 111(1):56-65. PubMed ID: 27084844
[TBL] [Abstract][Full Text] [Related]
4. SP1-induced SNHG14 aggravates hypertrophic response in in vitro model of cardiac hypertrophy via up-regulation of PCDH17.
Long Y; Wang L; Li Z
J Cell Mol Med; 2020 Jul; 24(13):7115-7126. PubMed ID: 32436661
[TBL] [Abstract][Full Text] [Related]
5. LncRNA AK045171 protects the heart from cardiac hypertrophy by regulating the SP1/MG53 signalling pathway.
Xu L; Wang H; Jiang F; Sun H; Zhang D
Aging (Albany NY); 2020 Feb; 12(4):3126-3139. PubMed ID: 32087602
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of lncRNA VDR/CASC15 induced by facilitates cardiac hypertrophy through modulating miR-432-5p/TLR4 axis.
Li C; Zhou G; Feng J; Zhang J; Hou L; Cheng Z
Biochem Biophys Res Commun; 2018 Sep; 503(4):2407-2414. PubMed ID: 29966657
[TBL] [Abstract][Full Text] [Related]
7. The long noncoding RNA XIST regulates cardiac hypertrophy by targeting miR-101.
Xiao L; Gu Y; Sun Y; Chen J; Wang X; Zhang Y; Gao L; Li L
J Cell Physiol; 2019 Aug; 234(8):13680-13692. PubMed ID: 30605239
[TBL] [Abstract][Full Text] [Related]
8. Targeting Transmembrane BAX Inhibitor Motif Containing 1 Alleviates Pathological Cardiac Hypertrophy.
Deng KQ; Zhao GN; Wang Z; Fang J; Jiang Z; Gong J; Yan FJ; Zhu XY; Zhang P; She ZG; Li H
Circulation; 2018 Apr; 137(14):1486-1504. PubMed ID: 29229612
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of long noncoding RNA VIM-AS1 and CTBP1-AS2 expression in type 2 diabetes.
Erfanian Omidvar M; Ghaedi H; Kazerouni F; Kalbasi S; Shanaki M; Miraalamy G; Zare A; Rahimipour A
J Cell Biochem; 2019 Jun; 120(6):9315-9323. PubMed ID: 30506719
[TBL] [Abstract][Full Text] [Related]
10. Long Noncoding RNA
Yu J; Yang Y; Xu Z; Lan C; Chen C; Li C; Chen Z; Yu C; Xia X; Liao Q; Jose PA; Zeng C; Wu G
Circ Heart Fail; 2020 Jan; 13(1):e006525. PubMed ID: 31957467
[TBL] [Abstract][Full Text] [Related]
11. LncRNA CTBP1-AS2 regulates miR-216a/ PTEN to suppress ovarian cancer cell proliferation.
Cui K; Zhu G
J Ovarian Res; 2020 Jul; 13(1):84. PubMed ID: 32711584
[TBL] [Abstract][Full Text] [Related]
12. SP1-SYNE1-AS1-miR-525-5p feedback loop regulates Ang-II-induced cardiac hypertrophy.
Wang Y; Cao R; Yang W; Qi B
J Cell Physiol; 2019 Aug; 234(8):14319-14329. PubMed ID: 30652310
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA cytoskeleton regulator RNA (CYTOR) modulates pathological cardiac hypertrophy through miR-155-mediated IKKi signaling.
Yuan Y; Wang J; Chen Q; Wu Q; Deng W; Zhou H; Shen D
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1421-1427. PubMed ID: 30794866
[TBL] [Abstract][Full Text] [Related]
14. Retinol-Binding Protein 4 Induces Cardiomyocyte Hypertrophy by Activating TLR4/MyD88 Pathway.
Gao W; Wang H; Zhang L; Cao Y; Bao JZ; Liu ZX; Wang LS; Yang Q; Lu X
Endocrinology; 2016 Jun; 157(6):2282-93. PubMed ID: 27100622
[TBL] [Abstract][Full Text] [Related]
15. LncRNA TINCR attenuates cardiac hypertrophy by epigenetically silencing CaMKII.
Shao M; Chen G; Lv F; Liu Y; Tian H; Tao R; Jiang R; Zhang W; Zhuo C
Oncotarget; 2017 Jul; 8(29):47565-47573. PubMed ID: 28548932
[TBL] [Abstract][Full Text] [Related]
16. LncRNA CTBP1-AS2 is upregulated in osteoarthritis and increases the methylation of miR-130a gene to inhibit chondrocyte proliferation.
Zhang H; Li J; Shao W; Shen N
Clin Rheumatol; 2020 Nov; 39(11):3473-3478. PubMed ID: 32388751
[TBL] [Abstract][Full Text] [Related]
17. LncRNA CTBP1-AS2 sponges miR-216a to upregulate PTEN and suppress endometrial cancer cell invasion and migration.
Wang QA; Yang Y; Liang X
J Ovarian Res; 2020 Apr; 13(1):37. PubMed ID: 32293505
[TBL] [Abstract][Full Text] [Related]
18. Transcribed Ultraconserved Regions, Uc.323, Ameliorates Cardiac Hypertrophy by Regulating the Transcription of CPT1b (Carnitine Palmitoyl transferase 1b).
Sun Y; Fan W; Xue R; Dong B; Liang Z; Chen C; Li J; Wang Y; Zhao J; Huang H; Jiang J; Wu Z; Dai G; Fang R; Yan Y; Yang T; Huang ZP; Dong Y; Liu C
Hypertension; 2020 Jan; 75(1):79-90. PubMed ID: 31735087
[TBL] [Abstract][Full Text] [Related]
19. Myocyte-specific enhancer factor 2C: a novel target gene of miR-214-3p in suppressing angiotensin II-induced cardiomyocyte hypertrophy.
Tang CM; Liu FZ; Zhu JN; Fu YH; Lin QX; Deng CY; Hu ZQ; Yang H; Zheng XL; Cheng JD; Wu SL; Shan ZX
Sci Rep; 2016 Oct; 6():36146. PubMed ID: 27796324
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA XXYLT1-AS2 regulates proliferation and adhesion by targeting the RNA binding protein FUS in HUVEC.
Wang Q; Yang Y; Fu X; Wang Z; Liu Y; Li M; Zhang Y; Li Y; Li PF; Yu T; Chu XM
Atherosclerosis; 2020 Apr; 298():58-69. PubMed ID: 32171981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
